Home » Topics » BioWorld Science

BioWorld Science
RSS

Janssen synthesizes new cyclopentyl nucleoside analogues

July 3, 2020

New E-NPP 2 inhibitors identified at Roche

July 3, 2020

CREDO 2 pivotal global phase III study of olokizumab meets endpoints

July 3, 2020

Yuhan discovers semicarbazide-sensitive amine oxidase inhibitors

July 3, 2020

LAMC2 identified as a therapeutic target in PDAC

July 3, 2020

Phase III study of pracinostat plus azacytidine in AML discontinued due to lack of efficacy

July 3, 2020

Meissa completes pre-IND meeting for COVID-19 vaccine candidate MV-014-210

July 3, 2020

Programmed necrosis has role in post-flu bacterial infections

July 3, 2020

MANIFEST study results of CPI-0610 in advanced myelofibrosis set up phase III study

July 3, 2020

Shock and kill with less toxicity

July 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...